Nearly 200 scientists warn of cellphone health risks
RT | May 13, 2015
Biological and health scientists from Russia and Iran to the USA are calling on the UN, the World Health Organization and national governments to develop strict regulations concerning devices and cellphones that create electromagnetic fields.
The scientists are from 39 nations and have authored 2,000 peer-reviewed papers on the health and biological effects of non-ionizing radiation, which is part of the electromagnetic field spectrum. In a letter, they say that devices like cellphones pose risks of cancer, genetic damage, changes in reproductive system, and learning and memory deficits.
“Putting it bluntly they are damaging the living cells in our bodies and killing many of us prematurely,” said Dr. Martin Blank, from the Department of Physiology and Cellular Biophysics at Columbia University, in a video message.
“We have created something that is harming us, and it is getting out of control. Before Edison’s light bulb there was very little electromagnetic radiation in our environment. The levels today are very many times higher than natural background levels, and are growing rapidly because of all the new devices that emit this radiation.”
One example that was cited is the cellphone. Blank pointed to a study which showed that as cellphone usage has spread widely, the incidence of fatal brain cancer in younger people has more than tripled.
The scientists see the unregulated use of radio frequency radiation in cellphones and Wi-Fi as developing into a public health crisis. Blank said biologists and scientists are not being heard from committees that set safety standards, that safety limits are much too high and that biological facts are being ignored.
“They are not protective,” he added. “We are really all part of large biological experiment without our informed consent. To protect ourselves, our children, and our ecosystem, we must reduce exposure by establishing more protective guidelines.”
Scientists are appealing to the United Nations Environmental Programme (UNEP) to “convene and fund an independent multidisciplinary committee to explore the pros and cons of alternative to current practices that could substantially lower human exposure to RF and ELF fields.”
They request that the deliberations be “transparent and impartial,” and involve industry players in the field. However, scientists believe industry “should not be allowed to bias the process or conclusions.” Once completed, the analysis would offer the UN and WHO a guide for precautionary action.
Questions have surfaced about the safety of EMF among the scientific community and with the public, but it is largely absent from national debate despite the ubiquitous use of devices, particularly in the United States.
“…In the United States, where non-industry-funded studies are rare, where legislation protecting the wireless industry from legal challenges has long been in place…to suggest it might be a problem – maybe, eventually, a very public-health problem – is like saying our shoes might be killing us,” wrote journalist Christopher Ketchum in a 2010 GQ article called “Warning: Your Cell Phone May Be Hazardous to Your Health.”
Ketchum said a 2008 study sponsored by the International Agency for Research on Cancer in France reported that after a decade of cellphone use, the chances of getting a brain tumor – specifically on the side of the head where you use the phone – go up as much as 40 percent for adults.
Read more: Berkeley to vote on ‘right to know’ law on cellphone radiation risks
Psychiatric drugs kill 500k+ Western adults annually, few positive benefits – leading scientist
RT | May 13, 2015
Psychiatric drugs lead to the deaths of over 500,000 people aged 65 and over annually in the West, a Danish scientist says. He warns the benefits of these drugs are “minimal,” and have been vastly overstated.
Research director at Denmark’s Nordic Cochrane Centre, Professor Peter Gøtzsche, says the use of most antidepressants and dementia drugs could be halted without inflicting harm on patients. The Danish scientist’s views were published in the British Medical Journal on Tuesday.
His scathing analysis will likely prove controversial among traditional medics. However, concern is mounting among doctors and scientists worldwide that psychiatric medication is doing more harm than good. In particular, they say antipsychotic drugs have been over-prescribed to many dementia patients in a bid to calm agitated behavior.
Gøtzsche warns psychiatric drugs kill patients year in year out, and hold few positive benefits. He says in excess of half a million citizens across the Western world aged 65 and over die annually as a result of taking these drugs.
“Their benefits would need to be colossal to justify this, but they are minimal,” he writes.
“Given their lack of benefit, I estimate we could stop almost all psychotropic drugs without causing harm.”
Gøtzsche, who is also a clinical trials expert, says drug trials funded by big pharmaceutical companies tend to produce biased results because many patients took other medication prior to the tests.
He says patients cease taking the old drugs and then experience a phase of withdrawal prior to taking the trial pharmaceuticals, which appear highly beneficial at first.
The Danish professor also warns fatalities from suicides in clinical trials are significantly under-reported.
In the case of antidepressants venlafaxine and fluoxetine, Gøtzsche casts doubt over their efficacy. He said depression lifts in placebo groups given fake tablets almost as promptly as groups who partake in official clinical tests.
He also stressed the results of trials of drugs used to treat schizophrenia are disconcerting, while those for ADHD are ambiguous.
Commenting on the negative side effects of such pharmaceutical drugs, Gøtzsche argued the “short-term relief” appears to be replaced by “long term harm.”
“Animal studies strongly suggest that these drugs can produce brain damage, which is probably the case for all psychotropic drugs,” he said.
“Given their lack of benefit, I estimate we could stop almost all psychotropic drugs without causing harm – by dropping all antidepressants, ADHD drugs and dementia drugs … and using only a fraction of the antipsychotics and benzodiazepines we currently use.”
“This would lead to healthier and more long-lived populations.”
Gøtzsche says psychotropic drugs are “immensely harmful” if used for prolonged periods.
“They should almost exclusively be used in acute situations and always with a firm plan for tapering off, which can be difficult for many patients,” he adds.
Gøtzsche’s views are sharply contradicted by many experts in the field of mental health. But others, including a diverse group of medical experts and institutions affiliated with the Nordic Cochrane Centre, argue otherwise. The Nordic Cochrane Centre is an independent research hub dedicated to scrutinizing and monitoring the effects of health care.
The debate on psychiatric drugs has gathered momentum in recent times. In the discussion, published in the British Medical Journal (BMJ), Gøtzsche’s arguments are contradicted by Professor of Mood Disorders Allan Young and John Crace. Crace, himself a psychiatric patient, writes for the Guardian.
Crace and Young say a broad body of research indicates the drugs are effective and that they are just as helpful as drugs for other ailments. They also argue mental health conditions are the fifth most significant contributor to disabilities worldwide.
While Gøtzsche stresses clinical trials bankrolled by pharma giants churn out skewered results, Young and Crace say the efficacy and safety of psychiatric medication continues to be monitored after research trials come to a close.
However, both Young and Crace acknowledge concern over the side effects and effectiveness of psychiatric medication.
“For some critics, the onus often seems to be on the drug needing to prove innocence from causing harm rather than a balanced approach to evaluating the available evidence,” they write.
“Whether concerns are genuine or an expression of prejudice is not clear, but over time many concerns have been found to be overinflated.”
The BMJ discussion is a preamble to the Maudsley debate at Kings College London on Wednesday. The debate takes place three times a year at the university’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN).
Wednesday’s debate focuses on the impacts of psychiatric medications, and poses the question of whether they prove more destructive for patients than beneficial.
FDA fails to report fraud in clinical trials – study
RT | February 10, 2015
The Food and Drug Administration (FDA) routinely fails to report evidence of fraud or misconduct when it inspects the way researchers conduct clinical trials, leaving the public unaware of which research is credible and which isn’t.
Researchers at New York University found that in dozens of published papers where the FDA had uncovered faults in clinical trials, only three ever indicated that violations occurred. In a stem cell trial, for example, all patients were said to have experienced improvement – despite one having a foot amputated.
The New York University study examined 57 clinical trials that received a notice of violation from the FDA for poor record keeping, false information, and poor patient study. Researchers found that findings from those clinical trials were used in 78 published papers – but only in three instances were the faults in the clinical trials mentioned in the papers.
In the other cases, none of the published papers containing data from faulty trials were corrected or retracted.
“These are major things,” Professor Charles Seife, the study’s author, told Reuters. “No one really knows unless you go through these documents that anyone is question the integrity of the trials.”
In one case, an entire clinical trial was considered unreliable by the FDA, but the published paper didn’t mention the violation at all. In another trial, researchers covered up a patient’s death.
Of the 57 published clinical trials, 39 percent had evidence of false information, 25 percent reported adverse events, 61 percent had record keeping problems, and 35 percent failed to protect the safety of the patient or had issues with oversight or informed consent.
“The FDA has repeatedly hidden evidence of scientific fraud not just from the public, but also from its most trusted scientific advisers, even as they were deciding whether or not a new drug should be allowed on the market,” Seife wrote at Slate. “For an agency devoted to protecting the public from bogus medical science, the FDA seems to be spending an awful lot of effort protecting the perpetrators of bogus science from the public.”
Seife said his team could have uncovered even more instances from the 600 clinical trials mentioned in the documents, but most of the documents obtained from the FDA were heavily redacted. “In some cases, you can’t even tell which drug is being tested,” he said.
Every year, the FDA inspects several hundred clinical sites performing biomedical research on human participants and occasionally finds evidence of violations of good clinical practices and misconduct. The study said, however, that the FDA has no systematic method for communicating these findings to the scientific community, and its findings go unremarked in peer-reviewed literature.
In a statement to Reuters, the FDA said it is “committed to increasing the transparency of compliance and enforcement activities with the goal of enhancing the public’s understanding of the FDA’s decision, promoting the accountability of the FDA, and fostering an understanding among regulated industry about the need for consistently safe and high-quality products.”
READ MORE:
US spends most on this drug… and no one knows how it works
GMO potato seeks FDA approval, opponents say safety risks remain
Monsanto agrochemicals causing genetic damage in soybean workers – study
RT | January 22, 2015
Soybean workers exposed to the agrochemicals like glyphosate, the main component in Monsanto’s ‘Roundup’ herbicide and other biocides, suffer from elevated DNA and cell damage, according to a new study.
The study, published in the journal Mutation Research/Genetic Toxicology and Environmental Mutagenesis, involved 127 people, including 81 exposed to biocides while working in the Brazilian soybean industry and 46 non-exposed individuals in a control group.
The exposed group exhibited an elevated level of cellular apoptosis, as well as DNA damage, according to researcher Danieli Benedetti and his team, which concluded that the now-common use of genetically-modified soybeans in the State of Rio Grande do Sul, especially in the city of Espumoso, has toxic ramifications for workers.
“Our findings indicate the advisability of monitoring genetic toxicity in soybean farm workers exposed to pesticides,” the researchers said.
Genetically-engineered seeds, proliferated across the globe by multinational agribusiness conglomerates like Monsanto, are designed to withstand dousing by glyphosate and other biocides in order to terminate insect, fungus, and weed nuisances.
Benedetti’s team focused specifically on Glyphosate and 2,4-D, the two top biocide components in American-biotechnology farming culture. Glyphosate is the prime ingredient in Monsanto’s Roundup products, while Dow Chemical’s 2,4-D is a potent herbicide that was also used in making Agent Orange, the chemical used by the US to devastate resistance during the Vietnam War.
Last spring, Brazil’s public prosecutor sought to suspend use of glyphosate based on its toxic effects. Studies have linked glyphosate to a fatal kidney disease that has affected poor farming regions worldwide.
Just last week, Monsanto won final approval from the US for its new genetically-modified soybeans and cotton, designed to withstand a dominant biocide that fights weed resistance built up as a result of the company’s glyphosate-based Roundup herbicide already in use.
Monsanto reported an earnings drop of 34 percent in its first fiscal quarter. The company reportedly lost $156 million in the fourth quarter of last year due to a one-time payment made to settle an environmental legal case.
As multinationals such as Monsanto and Dow Chemical have sought strict standardization in agriculture markets the world over, the corporate leviathans, especially the former, have become the target of considerable protests and demonstrations.
Companies like Monsanto market their own patented seeds that, given their genetic modification, can be doused with biocides to kill pests and weeds, and which can jeopardize long-term health of the soil and the necessary biodiversity of a local environment that allows for natural pollination and, thus, food security.
In May of last year, activists on five continents around the globe, comprising of 52 nations organized resistance under the ‘March against Monsanto’ umbrella. Protests positioned against Monsanto and involving other corporate-food issues occurred in around 400 cities worldwide, according to reports.
Just this past weekend, more than 120 organizations joined the fifth annual ‘We are Fed Up!’ demonstration in Berlin to focus on the increased importation of American farming practices – such as genetic modification, frequent antibiotic injections for animals, and chemical meat treatments – following the implementation of the controversial Transatlantic Trade and Investment Partnership (TTIP).
Protests have raged most furiously in Europe, where the EU recently approved a law that would let its nations ban genetically-modified organisms even if the EU had deemed them safe. Monsanto said last year it would not try to get any more GM crops approved in Europe given the consistent pushback.
Anger and unrest against Monsanto’s stranglehold has also spread to South America. In Argentina, protests have occurred in resistance to the company’s potent biocides used in tandem with their genetically-engineered seeds. In Brazil, farmers have called on Monsanto and other producers of pest-resistant corn seeds to reimburse them for money spent on additional biocides when the bugs killed the crops instead of dying themselves, speaking to the biocide arms race involved in using GM seeds. Brazilian soy exporters are also tangling with Monsanto over seed royalties.
In Central America, Guatemala’s highest court suspended in September a controversial ‘Monsanto Law,’ a provision of a US-Central American trade agreement, that would insulate transnational seed corporations considered to have “discovered” new plant varieties.
On its home turf in the United States, Monsanto has worked diligently with other multinational biotech, agribusiness, and food production companies to beat down state-level proposals to simply label whether food is comprised of GM ingredients.
The most recent example came in the state of Oregon, where a November ballot initiative to require GMO labeling was narrowly defeated in what became the most expensive ballot measure in the state’s history. The likes of Monsanto and Dupont flushed more than $21 million into the anti-labeling campaign, dwarfing the $9 million raised by proponents.
The company has sued Hawaii’s Maui County for passing last year that bans the cultivation of genetically modified organisms.
Monsanto’s St. Louis headquarters have been the target of mild protests, especially during shareholder meetings.
Meanwhile, agribusiness allies on Capitol Hill are pushing new federal legislation, the Safe and Accurate Food Labeling Act, that would standardize food labeling, effectively killing popular state-based efforts to pass labeling laws.
READ MORE:
Monsanto gets approval for new GMO corn, soybeans designed for potent new biocide
Rising suicide rate for Indian farmers blamed on GMO seeds
In facts & numbers: Absolute majority of Americans want GMO food to be labeled
NSA to open new $60mln facility in N. Carolina university amid surveillance scrutiny
RT | August 16, 2013
While new disclosures this week have exposed inept oversight and gross privacy violations within the National Security Agency, news out of North Carolina has revealed that the NSA is spending $60.75 million on another brand new facility.
In the midst of an international debate focused on how the United States’ premier spy agency has conducted dragnet surveillance over much of the world, including at home, the NSA is expanding even further. The News & Observer reported on Thursday that North Carolina State University in Raleigh, NC is receiving a $60.75 million grant from the NSA to develop a top-secret data analysis lab.
The grant, the paper reported, is three times larger than any award ever received by the university in the school’s history.
Randy Woodson, the school’s chancellor, said Thursday that the deal had been in the works for three years. He said he hoped the data center would make North Carolina a more attractive destination for technology companies. Woodson predicted that the project would create 100 jobs over five years.
“We appreciate the confidence of the National Security Agency to select NC State for this groundbreaking endeavor,” Woodson said in a statement. “Not only will it enhance the academic experience for our students and faculty, it will also add to the economic prosperity of our community through new jobs, new industry and new partnerships.”
Many details on the project have been kept secret because of national security, according to officials. But North Carolina State already has contracts with the Department of Defense, helping the agency research technology which will help soldiers identify improvised explosive devices and expand their foreign language capabilities, among other functions.
The NSA has come under harsh scrutiny in recent months due to the disclosure of classified surveillance programs which the government has used to justify monitoring the communications of Americans, as well as the international community. Internal emails published by the News & Observer reveal that North Carolina State originally intended to announce their deal with the NSA just before the leaks were published but decided to delay in fear of potential blowback.
“A very important announcement about our new NSA-funded Laboratory for Analytic Sciences was supposed to be made public this morning, but with that bit out of The Guardian newspaper on NSA collecting phone records of Verizon customers – everyone thought it best to not make the announcement just yet,” Randy Avent, the associate vice chancellor for research at NCSU, wrote in a message to other administrators. “By the way – our Lab is just that – a research program studying the fundamental science behind analytics. It is not a storage facility for classified data and does not work with any data like that mentioned in the article.”
The delayed announcement comes after another disclosure which further harmed the NSA’s reputation. The Washington Post published top-secret documents Thursday night which provide a glimpse into just how often the NSA breaks the law and invades the privacy of Americans. Thousands of violations were recorded in each of the years since the NSA’s power was expanded in 2008.
